| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K13185470 |
| PharmacoGx | BRD-K13185470 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGIF2LX | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | TBC1D3F | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | GALNT5 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | FRMD6 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | C6orf15 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | SBK2 | CTRPv2 | pan-cancer | AAC | 0.63 | 0.03 |
| mRNA | RAB23 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | SLC13A5 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | RNF128 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | GID8 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
